SAPIENCETHERAPEUTICS.COM KEYWORD DENSITY CHECKER

Total words: 4134 | 2-word phrases: 1020 | 3-word phrases: 1251 | 4-word phrases: 1403

PAGE INFO

Title Try to keep the title under 60 characters (28 characters)
Home - Sapience Therapeutics
Description Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (45 characters)
Targeting Cancer at the Source of the Disease

ONE WORD PHRASES 460 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1therapeutics8618.70%
2sapience8217.83%
3more7917.17%
4the5010.87%
5of4710.22%
6at4610.00%
7st101398.48%
8to347.39%
9for296.30%
10cancer286.09%

TWO WORD PHRASES 1020 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1sapience therapeutics626.08%
2more sapience615.98%
3at the262.55%
4therapeutics to222.16%
5therapeutics announces212.06%
62022read more201.96%
7to present171.67%
82021read more161.57%
9annual meeting141.37%
10present at141.37%
112023read more111.08%
12on st101100.98%
13st101 a90.88%
14phase 180.78%
152020read more80.78%
16phase 280.78%
17st101 in80.78%
18poster presentation70.69%
192 study70.69%
20november 170.69%

THREE WORD PHRASES 1251 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1more sapience therapeutics443.52%
2sapience therapeutics to191.52%
3therapeutics to present161.28%
42022read more sapience161.28%
5sapience therapeutics announces151.20%
6to present at131.04%
72021read more sapience110.88%
8present at the90.72%
92023read more sapience80.64%
10aacr annual meeting60.48%
112020read more sapience60.48%
12association for cancer60.48%
13american association for60.48%
14research aacr annual60.48%
15presentation on st10150.40%
16in patients with50.40%
17on st101 at50.40%
181 2022read more50.40%
19cancer research aacr50.40%
20for cancer research50.40%
21therapeutics announces poster50.40%
222019read more sapience50.40%
23at the american40.32%
24at the 202340.32%
259 2021read more40.32%
262 study in40.32%
272024read more sapience40.32%
28phase 2 study40.32%
29overview st101 st31640.32%
30national cancer institute40.32%

FOUR WORD PHRASES 1403 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1more sapience therapeutics to151.07%
2sapience therapeutics to present141.00%
3therapeutics to present at120.86%
4more sapience therapeutics announces100.71%
52022read more sapience therapeutics90.64%
6to present at the80.57%
72021read more sapience therapeutics70.50%
8research aacr annual meeting60.43%
92023read more sapience therapeutics60.43%
10american association for cancer50.36%
11association for cancer research50.36%
12cancer research aacr annual50.36%
132019read more sapience therapeutics40.29%
142020read more sapience therapeutics40.29%
15sapience therapeutics announces poster40.29%
162024read more sapience therapeutics40.29%
17for cancer research aacr40.29%
187 2020read more sapience30.21%
19phase 2 study in30.21%
201 2022read more sapience30.21%
21present at the 201930.21%
22on st101 at the30.21%
23grant from national cancer30.21%
24therapeutics announces first patient30.21%
25announces poster presentation on30.21%
26therapeutics announces poster presentation30.21%
27conference on molecular targets30.21%
28to present at bio30.21%
29on molecular targets and30.21%
30sapience therapeutics announces first30.21%
31for the treatment of30.21%
32of cancer sitc 37th20.14%
33track designation for st10120.14%
34fast track designation for20.14%
35fda fast track designation20.14%
36receives fda fast track20.14%
37sapience therapeutics announces oral20.14%
38for immunotherapy of cancer20.14%
39society for immunotherapy of20.14%
40at society for immunotherapy20.14%

EXTERNAL LINKS

# URL Whois Check
1https://www.linkedin.com/company/sapience-therapeutics-inc- Whoislinkedin.com